Skip to content
  • Sunday, 26 July 2026
  • 2:52 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Cornell University Scientists Achieve Breakthrough in Developing Reversible and Nonhormonal Male Contraceptive Through Targeted Meiotic Interruption
Stem Cell & Regenerative Medicine

Cornell University Scientists Achieve Breakthrough in Developing Reversible and Nonhormonal Male Contraceptive Through Targeted Meiotic Interruption

Dwi Wanna Jul 13, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant advancement in the pursuit of…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Achieve Breakthrough in Reversible Nonhormonal Male Contraception through Targeted Meiotic Interruption

Dwi Wanna Jun 5, 2026 0

In a significant advancement for reproductive medicine, researchers at Cornell University have successfully demonstrated a method for a safe, reversible,…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male Contraception Through Meiotic Inhibition

Dwi Wanna May 29, 2026 0

The pursuit of a reliable, reversible, and nonhormonal male contraceptive has long been described by the medical community as the…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Develop Breakthrough Reversible Nonhormonal Male Contraceptive Through Targeted Meiotic Disruption

Dwi Wanna May 22, 2026 0

In a significant advancement for reproductive medicine, a team of researchers at Cornell University has announced a major breakthrough in…

Read More
Stem Cell & Regenerative Medicine

Cornell University scientists develop a safe reversible and long-acting nonhormonal male contraceptive through targeted meiotic disruption

Dwi Wanna Apr 30, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for nonhormonal male contraception…

Read More
Stem Cell & Regenerative Medicine

Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic Interruption

Dwi Wanna Apr 15, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant advancement in the quest for…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Breakthrough Meiotic Pathway for Reversible Nonhormonal Male Contraception

Dwi Wanna Apr 8, 2026 0

In a significant advancement for reproductive medicine, researchers at Cornell University have announced a major breakthrough in the pursuit of…

Read More
Canada’s Drug Agency Data Reveals Evolving Landscape of Drug Approvals and ReimbursementTWiV 1292: Clinical update with Dr. Daniel GriffinUC San Francisco Researchers Identify FTL1 Protein as Key Driver of Hippocampal Aging and Memory Loss in New StudyScientists Engineer Stable Optical Tornadoes in Miniature Structures Using Liquid Crystals and Synthetic Magnetic Fields to Advance Quantum Photonics
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ